3 ms·
The article states: >Bogunovic’s therapy is designed to mimic what happens in people with ISG15 deficiency, but only for a short time. Given the choice betwee
by 0xDEAFBEAD 1y ago
The article states:
>Bogunovic’s therapy is designed to mimic what happens in people with ISG15 deficiency, but only for a short time.
Given the choice between 2 weeks of a moderate COVID infection (fever but no hospitalization), and 2 weeks of this therapy, I would guess that the moderate COVID infection gets you at least 10x the inflammation.